Replimune Group, Inc.
REPLNasdaqCIK 1737953HealthcareFiscal year ends Mar 31
Reports and events: 169 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2807:25 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001628280-26-067722 |
| 2026-10-2807:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-119354 |
| 2026-09-1616:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-108243 |
| 2026-08-1416:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-057099 |
| 2026-08-1408:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-096483 |
| 2026-08-1117:50 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-094196 |
| 2026-08-1118:37 ET | 8-K/A | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-093512 |
| 2026-08-1007:50 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-093042 |
| 2026-08-0721:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-092246 |
| 2026-07-3120:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-088857 |
| 2026-07-3008:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-088481 |
| 2026-07-2918:14 ET | DEF 14A | Proxy statementPeriod 2026-09-15 | 0001104659-26-087650 |
| 2026-06-2908:12 ET | 10-K | Annual reportPeriod 2026-03-31 | 0001628280-26-045886 |
| 2026-06-2908:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-078511 |
| 2026-06-2608:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-078009 |
| 2026-05-2909:56 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-068002 |
| 2026-04-1317:59 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-042141 |
| 2026-02-0308:12 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001628280-26-004805 |
| 2026-02-0308:05 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-26-009510 |
| 2026-01-1208:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002721 |
| 2025-11-0608:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107438 |
| 2025-11-0608:07 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-049884 |
| 2025-10-2007:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-100605 |
| 2025-09-1809:20 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-091066 |
| 2025-09-0416:05 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-087464 |
| 2025-08-0708:07 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001737953-25-000013 |
| 2025-08-0708:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-074989 |
| 2025-07-2516:16 ET | DEF 14A | Proxy statementPeriod 2025-09-03 | 0001104659-25-070833 |
| 2025-07-2208:18 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-069489 |
| 2025-06-2416:30 ET | 8-K | 7.01 Regulation FD disclosure | 0001104659-25-062122 |
| 2025-05-2217:12 ET | 10-K | Annual reportPeriod 2025-03-31 | 0001737953-25-000009 |
| 2025-05-2208:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-051847 |
| 2025-03-0717:07 ET | SCHEDULE 13D | Ownership report, active investor | 0001104659-25-021795 |
| 2025-03-0716:30 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-021756 |
| 2025-02-1208:07 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001737953-25-000004 |
| 2025-02-1208:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-011851 |
| 2025-01-2217:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-005291 |
| 2024-12-0408:30 ET | 8-K/A | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-125370 |
| 2024-11-2708:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-123451 |
| 2024-11-2608:30 ET | 8-K | 8.01 Other events | 0001104659-24-122860 |
| 2024-11-2117:26 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-121616 |
| 2024-11-1208:16 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001737953-24-000015 |
| 2024-11-1208:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-116413 |
| 2024-09-0516:05 ET | 8-K | 5.07 Shareholder vote results | 0001104659-24-097365 |
| 2024-08-0808:06 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001737953-24-000013 |
| 2024-08-0808:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-087035 |
| 2024-07-1916:15 ET | DEF 14A | Proxy statementPeriod 2024-09-04 | 0001104659-24-081167 |
| 2024-06-1308:36 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-071078 |
| 2024-06-0609:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-068948 |
| 2024-06-0309:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-067556 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:44 ET. Listed shows no prices and gives no investment advice.